Micra Functional Testing on pNGHT and NGHT
Medtronic, Inc. · Decision date Sep 8, 2026
What did the FDA decide?
The FDA recorded decision OK30 for PMA supplement P150033/S230, dated 2026-09-08, submitted by Medtronic, Inc. as a 30-Day Notice. The supplement covers testing of hybrid electronic module subassemblies on a new or modified hybrid subassembly test system, filed under the process change reason for manufacturer, sterilizer, packager or supplier. The product code is PNJ, device category leadless pacemaker, specialty cardiovascular.
This is a supplement to an existing PMA rather than an approval of a new device or of the whole system. The record does not identify which Micra model or component the hybrid electronic module belongs to, what the test system change involves, or what evidence supported the decision. The source lists no documents, so the decision order and any conditions cannot be reviewed here. Whether the change affects marketed device performance is not stated in the available data.
FDA approval order statement
testing the hybrid electronic module subassemblies on a new/modified hybrid subassembly test system
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 8, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P150033/S230
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic, Inc.
- Product code
- PNJ
- Decision code
- OK30
- Decision date
- Sep 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Leadless pacemaker.
- Applicant
- Medtronic, Inc.
- Product code
- PNJ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P150033. Subsequent supplements may change the device or its indications.
FDA decision timeline
P150033 · Original PMA
MEDTRONIC MICRA TRANSCATHETER PACEMAKER SYSTEM
P150033/S230 received
Application receipt date recorded by FDA.
P150033/S230 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P150033. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150033
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA approval | Apr 6, 2016 | FDA |
Explore the linked device profile
Other records with product code PNJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
AVEIR VR Real-World Evidence StudyP150035/S042 | ABBOTT MEDICAL | PMA supplement | Oct 21, 2026 | FDA |
Aveir VR Leadless SystemP150035 | ABBOTT MEDICAL | PMA approval | Mar 31, 2022 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P150033/S230
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

